MTND4P11

Across TCGA pan-cancer cohorts, MTND4P11 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MTND4P11 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MTND4P11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND4P11 expression acts as an unfavorable survival marker, although some lineages such as OV and BRCA show a favorable association.

KIRP, COAD, and LIHC are the cancer types where MTND4P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	II,III,IV	0.311	0.740	<.001	62	view →
COAD	OS	Tertile	III,IV	0.119	0.595	<.001	42	view →
LIHC	DFS	Quartile	III,IV	0.142	0.411	<.001	39	view →
KICH	OS	Tertile	III,IV	0.467	0.941	.006	33	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
TGCT	DFS	Tertile	All	0.499	0.699	.045	6	view →
OV	DFS	Quartile	All	0.189	0.121	.035	6	view →
ACC	OS	Tertile	III,IV	0.164	0.499	.013	6	view →
BRCA	OS	Tertile	II,III,IV	0.934	0.903	.037	4	view →
LUAD	OS	Quartile	III,IV	0.559	0.692	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MTND4P11–KIRP (DFS)

Open the KIRP breakdown →